TEVA Pharmaceuticals and
Allergan overnight confirmed that
Teva will buy Allergan’s generic
drug business (PD yesterday), with
Teva also formally withdrawing its
rival offer for Mylan.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 28 Jul 15 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 28 Jul 15
LEADING pharmacy, consumer and Federal agencies want to see better use of existing funding and leverage digital health resources to improve quality use of medicines, discussions at the Medicines Safety Forum in Canberra revealed.